Sign In
Buy PIII
$10.05
-2.74 (-21.42%)
At Close: Jun 03, 2026
P3 Health Partners to Report Fourth-Quarter and Full-Year 2022 Financial Results on March 30
08:25am, Friday, 24'th Mar 2023
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that the
P3 Health Partners Reaffirms 2022 Growth Over 61% And Path To Profitability
12:43am, Wednesday, 22'nd Feb 2023
P3 Health Partners' guidance breaks the billion-dollar mark in 2022 revenues. P3 Health Partners anticipates that its Adjusted EBITDA will be positive in 2024.
P3 Health Partners Inc. Could Be A Good Play Eventually
09:26pm, Thursday, 19'th Jan 2023
P3 Health Partners has had a good quarter with the top line growing 59% YoY. The future looks bright as the management remains confident in opening another 20 facilities.
5 Best and Worst Performing Small-Cap Stocks in Dec 2022
10:59pm, Tuesday, 17'th Jan 2023
Small-cap stocks usually suffer more than mid- and large-cap stocks when the market as a whole is struggling, and when the market is rallying, they could offer higher returns as well.
P3 Health Partners to Present at the 41st Annual J.P. Morgan Healthcare Conference
05:00pm, Tuesday, 03'rd Jan 2023
HENDERSON, Nev.--( BUSINESS WIRE )-- P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, is participating
P3 Health Partners Inc. (PIII) Q3 2022 Earnings Call Transcript
04:16pm, Tuesday, 15'th Nov 2022
P3 Health Partners Inc. (NASDAQ:PIII ) Q3 2022 Results Conference Call November 14, 2022 4:30 PM ET Company Participants Karen Blomquist - Vice President of Investor Relations Sherif Abdou - Chief Exe
P3 Health Partners to Present Third Quarter 2022 Financial Results
04:30pm, Thursday, 10'th Nov 2022
HENDERSON, Nev.--( BUSINESS WIRE )--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced t
P3 Health Partners Inc. (PIII) Q2 2022 Earnings Call Transcript
06:22pm, Thursday, 20'th Oct 2022
P3 Health Partners Inc. (NASDAQ:PIII ) Q2 2022 Earnings Conference Call October 20, 2022 4:30 PM ET Company Participants Karen Blomquist - Vice President, Investor Relations Sherif Abdou - Chief Execu
P3 Health Partners to Present 1H 2022 Financial Results
08:30am, Thursday, 20'th Oct 2022
Management to Host Conference Call and Webcast
P3 Health Partners to Present Fourth Quarter and Full Year 2021 Financial Results
08:00am, Thursday, 14'th Apr 2022
Management to Host Conference Call and Webcast April 25, 2022 at 4:30 PM ET Management to Host Conference Call and Webcast April 25, 2022 at 4:30 PM ET
P3 Health Partners Expects To Clock 46% Jump In Q4 Sales, FY22 Guidance Surpass Consensus
10:38am, Wednesday, 09'th Mar 2022
P3 Health Partners Inc (NASDAQ: PIII) expects Q4 FY21 revenue of approximately $183 million, up 46% Y/Y, beating the consensus of $171 million. For FY21, the Company sees sales increase 32% to appro
P3 Health Partners to Participate at Upcoming Investor Conferences
08:30am, Monday, 07'th Mar 2022
HENDERSON, Nev., March 07, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners, Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company,
8 Penny Stocks To Buy Now According To Insiders In 2022
02:41pm, Tuesday, 08'th Feb 2022
Penny stocks to buy now according to insiders. The post 8 Penny Stocks To Buy Now According To Insiders In 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
5 Penny Stocks To Buy Now According To Insiders In 2022
11:05am, Tuesday, 01'st Feb 2022
Insiders are scooping up shares of these penny stocks in 2022. The post 5 Penny Stocks To Buy Now According To Insiders In 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | Pen
